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Multi-resistant methicillin-resistant Staphylococcus aureus (MMRSA) has been commonly reported to 
be one of the commonest causes of nosocomial infections worldwide. Also, recent reports describe 
methicillin-resistant S. aureus (MRSA) carriage in persons in the community. The study investigated its 
prevalence in urine of healthy women and its susceptibility pattern to other antibiotics. Urine samples 
collected from healthy women volunteers in Zaria were cultured and screened for S. aureus using 
standard microbiological procedures. The isolates were then subjected to antibiotic susceptibility 
testing using disc diffusion technique. A total of 54 (36%) S. aureus isolates were isolated from 150 
urine samples collected. The prevalence rate for married and single women was 31% and 46%, 
respectively. Of the S. aureus isolates, 37 (69%) were methicillin-resistant. The MRSA were highly 
resistant to ampicillin 100%, cephalexin 100%, clindamycin 92%, vancomycin 89% but had low 
resistance to pefloxacin 35%, ofloxacin 27% ciprofloxacin 27%, sparfloxacin 24% and gentamicin 16%.  
All the 37 (100%) MRSA isolates showed resistance to at least two antibiotics tested while 33 (89.2%) 
were multi-drug resistant. 
 





Methicillin-resistant Staphylococcus aureus (MRSA) is a 
serious threat to hospitalized patients globally and it now 
represents a challenge for public health; as community-
associated infections appear to be on the increase in 
both adults and children in various regions and countries 
(Layton et al., 1995). The overall incidence of MRSA 
isolation has gradually increased to reach levels of 
around 30% or more in some countries (Ayliffe, 1997). It 
was estimated that MRSA strains accounted for 84% of 
hospital-acquired S. aureus isolates and 45% of non-
hospital acquired S. aureus isolates in Taiwan in 1998 
(Ho et al., 1999). 
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the nasal cavities, skin, gastrointestinal, anuses, and 
vaginal vaults of healthy women. Approximately 60% of 
women harbour this organism intermittently at one or 
more body sites (von Eiff et al., 2001). Studies have 
shown that 7-25% of women harboured toxin-producing 
S. aureus (Warner and Onderdonk, 2004). However, 
most persons with MRSA are not infected.  MRSA may 
colonise mucosal and epithelial surfaces without causing 
any signs of inflammation or infection (Simor, 2001; 
Weems, 2001) but are at increased risk of becoming 
infected with these strains (Lowy, 1998). 
Resistance in MRSA is related to a chromosomal mecA 
gene that specifies the production of an abnormal 
penicillin binding protein called PBP2a or PBP21. 
Penicillin–binding proteins are membrane-bound 
enzymes, which targets for all β-lactam antibiotics.  
PBP2a has a decreased affinity for binding β-lactam 
antibiotics resulting in resistance not only to methicillin 
but   also   to   all   β-lactams   including   penicillins    and  




cephalosporins (Weems 2001). The mecA gene complex 
also contains insertion sites for plasmids and 
transposons that facilitate acquisition of resistance to 
other antibiotics.  Thus, cross-resistance to non-β-lactam 
antibiotics such as erythromycin, clindamycin, 
gentamicin, co-trimoxazole and ciprofloxacin is common 
(Chambers, 1979; Chambers, 2001).  Nevertheless, 
MRSA isolates susceptible to several non-β-lactam 
antibiotics have appeared in some European regions 
(Lelievre et al., 1999; Pournaras 2001). 
This study reports the prevalence and susceptibility 




MATERIALS AND METHODS 
 
Antibiotics and media 
 
Antibiotics discs were used with their concentrations and sources 
as follows: ampicillin 10 µg (Medreich sterilab, India), cephalexin 30 
µg (Fidson, India), ciprofloxacin (ciprotab®) 5 µg (Fidson, India), 
clindamycin (Dalacin C®) 2 µg (Pharmacia, Belgium), gentamicin 
(Hefogenta®) 10 µg (Wuham, china), methicillin 10 µg (Oxoid, UK), 
ofloxacin (Fluxor®) 5 µg (Pathoteq Lab, India), pefloxacin 
(Peflotab®) 5 µg (Fidson, India), sparfloxacin (Sparbact®) 5 µg 
(Pathoteq Lab. India) and vancomycin 30 µg (Dumex-Alpharma, S. 
Demark) 
Mannitol salt agar, Mueller Hinton agar II, Nutrient agar and 
Nutrient broth Media used were from LAB M (International 





First ‘clean catch” urine sample were collected randomly from 150 
healthy women who were classified into two groups: Married 
(pregnant women inclusive) and single of ages between 20-40 
years over a period of two (2) months from Zaria community after 
an informed consent had been obtained from each woman. All the 
volunteers were not on any antibiotics at the point of sampling. 
Samples (100 from married and 50 from single) were collected into 
labelled sterile bottles, kept in an iced-bag and transported to the 





Each urine sample was inoculated (in duplicates) into mannitol salt 
agar plates and incubated at 37°C for 24 h. The characteristic 
isolates were asceptically isolated and characterised using 
established microbiological methods, which include colonial 
morphology, Gram’s, stain reaction and biochemical characteristics 
(Cheesbrough, 2002).   Isolates that were Gram-positive cocci, 
catalase positive and coagulase positive were considered as S. 
aureus in this study. 
 
 
Definition of community-associated isolates 
 
For the purpose of this study, community-associated isolates were 
defined as isolates from the samples of the healthy women who 
were not on any antibiotic at the time of sampling and had not been 





Antimicrobial susceptibility testing 
 
The antimicrobial susceptibility pattern of the S. aureus isolates was 
determined using Kirby-Bauer-NCCLS modified disc diffusion 
technique (Cheesbrough, 2002). All the isolates were tested for 
sensitivity to ten (10) antibiotics. Standardised overnight culture of 
each isolate was used to flood the surface of Mueller Hinton agar 
(MHA) plates; excess drained off and allowed to dry while the lid 
was in plate. Standard antibiotic discs were asceptically placed at 
reasonable equidistance on the inoculated MHA plates and allowed 
to stand for 1 h. The plates (in duplicates for each isolates) were 
then incubated at 30°C for 24 h so as to favour the growth of 
methicillin resistant strains (BSAC 2002). The diameter of the zone 
of inhibition produced by each antibiotic disc was measured, 
recorded and the isolates were classified as “resistant”, 
“intermediate” and “sensitive” based on the standard interpretative 
chart updated according to the current NCCLS standard (BSAC, 
2002; NCCLS, 2002) and Fluka zone interpretative chart in 





Frequencies were obtained and percentages were calculated for 
study variables. Chi-square and two-tailed Fisher’s exact test were 
used to calculate probabilities and determine significance. A p-
value of less than or equal to 0.05 is considered to be statistically 
significant (P0.05).  
 
 
Table 1. Distribution of Staphylococcus aureus and MRSA 








Married 100 31 (31) 21 (68) 
Single 50 23  (46) 16 (70) 




RESULTS AND DISCUSSION 
 
A total of 54 (36%) S. aureus isolates were isolated from 
150 urine samples screened.  The prevalence rates from 
married and single women were 31% and 46%, 
respectively. Of the S. aureus isolated, 37 (69%) were 
methicillin-resistant (Table 1). 
The result of antibiotic susceptibility of methicillin-
resistant isolates to other antibiotics is shown in (Table 
2). The results show high resistance to ampicillin (100%), 
cephalexin (100%), clindamycin (92%), vancomycin 
(89%) but low resistance to pefloxacin (35%), ofloxacin 
(27%), ciprofloxacin (27%), sparfloxacin (24%) and 
gentamicin (16%).  
The prevalence of multi-drug resistance in the (MRSA) 
isolates is shown in Table 3. Multi-drug resistance was 
defined in this study as resistance to four or more of the 
antibiotics tested.  Thus, 33 (89.2%) of the MRSA 
isolates showed multi-drug resistance to the antibiotics 
and none was fully susceptible to all the tested 
antibiotics.  




               Table 2. Resistance pattern of MRSA isolates from healthy women in Zaria, Nigeria. 
 
Antibiotics Resistant No (%) Intermediate No (%) Susceptible No (%) 
Ampicillin (10 µg) 37 (100) 0 (0) 0 (0) 
Cephalexin (30 µg) 37 (100) 0 (0) 0 (0) 
Clindamycin (2 µg) 34 (92) 0 (0) 3 (8) 
Ciprofloxacin (5 µg) 10   (27) 3 (8) 24 (65) 
Gentamicin (10 µg) 6  (16) 0 (0) 31 (84) 
Ofloxacin (5 µg) 10   (27) 1     (3) 26   (70) 
Pefloxacin (5 µg) 13   (35) 1     (3) 23   (62) 
Sparfloxacin (5 µg) 9 (24) 1     (3) 27   (73) 




                                              Table 3. Prevalence of multiple-drug resistance among 37 MRSA isolates. 
 
Frequency of multi-drug resistance Parameter 
Number (%) 
Fully sensitive 0 0 
Resistant to 1 agent 0 0 
Resistant to 2 agent 3 8 
Resistant to 3 agent 1 3 
Resistant to 4 agents 18 49 
Resistant to 5 agents 4 11 
Resistant to 6 agents 1 3 
Resistant to 7 agents 0 0 
Resistant to 8 agents 7 19 




New strains of community-associated methicillin-
resistant S. aureus (CA-MRSA) that cause soft-tissue 
infections in healthy people have recently been detected 
worldwide (Vandenesch et al., 2003). Drug resistance in 
S. aureus including the emergence of MRSA in 
healthcare and community settings is an increasingly 
reported event that makes treating serious infection 
difficult. 
The carrier rate of S. aureus in this study was 31% and 
46% for urine of married and single women, respectively. 
This is in agreement with the report of Ehinmidu (2003). 
The difference in the colonization rate of S. aureus in the 
married and single women was not significant (P>0.05) 
indicating that marital status is not a notable factor in 
colonization and there is no activity or behaviour of any of 
the groups, which predisposes them to S. aureus 
infection. Also, the difference in MRSA colonization in the 
women groups was not significant (P>0.05). MRSA 
colonization may subsequently cause infections 
(Kluytmans et al., 1997). 
In this result, MRSA isolated show total resistance to 
ampicillin and cephalexin, which support the findings, that 
MRSA strains are equally resistant to all β-lactam 
antibiotics (Weems, 2001; Gross-Schulman et al., 1998) 
which may be due to the presence of chromosomal mecA 
gene that specifies the production of an abnormal 
penicillin binding protein (PBP2a) which has low affinity 
for binding β-lactam antibiotics.  A high resistance was 
observed to clindamycin (92%) and vancomycin (89%) in 
our study but this is contrary to the findings of earlier 
reports (Fridkin et al., 2005; Anupurba et al., 2003) that 
did show that community-based MRSA isolates had 87-
100% susceptibility to clindamycin and vancomycin. 
Thus, these antibiotics have been used in the treatment 
of MRSA infections. However, our findings support the 
reports by Olayinka et al. (2005) who observed 57.7% 
vancomycin-resistant S. aureus (VRSA) and Lu et al. 
(2005) who found 92.9% CA-MRSA isolates resistance to 
clindamycin. These findings also support the recent 
alarming increasing emergence of vancomycin resistance 
of S. aureus worldwide (Fridkin, 2001). 
There is a high level of MRSA susceptibility to 
gentamicin and the fluoroquinolones tested in this study. 
This may be due to the absence of resistance conferring-
genes in these MRSA strains as reported by Polyzou et 
al.,  2001).  The  observed  high  MRSA  susceptibility   to  
gentamicin and fluoroquinolones in this study support 
some previous reports (Fridkin et al., 2005; Nordmann 
and Nass, 2005). Thus, the existence of MRSA 
susceptible to these non β-lactam antibiotics may provide  




an opportunity for the recommendation of these drugs for 
empirical treatment of community-associated MRSA 
strains and further reducing reliance on vancomycin. 
The high level of multiple drug resistance shown by the 
MRSA isolates from healthy volunteers in this study is of 
great concern. All the MRSA isolates showed resistance 
to at least two antibiotics tested in this study, indicating 
the presence of strong selective pressure from antibiotics 
use in this community. This confirms the postulation that 
healthy members of the community are the highest 
reservoir of antimicrobial resistant bacteria (Lamikanra et 
al., 1996). The high prevalence rate of multi-drug 
resistant MRSA in the urine of healthy women 
investigated in the community demand serious concern.  
There is an urgent need to adopt basic principles of 
asepsis and high personal hygiene, for most 
staphylococcal infections are readily transmitted among 
susceptible populations by the individuals who have 
acquired them by hospitalization. Our study however 
involved only a small number of isolates, so we 
recommend a multi-centre study to be done to determine 
the true prevalence of MRSA in both community and 
hospital settings.  
The central focus of this study is on women because of 
the inevitable vital role they play in human race as wives 
and mothers. Studies have shown that 60% of women 
harbour S. aureus (including the toxin producing ones) 
intermittently at one or more body sites (Daghistani et al., 
2000, von Eiff et al., 2001; Warner and Onderdonk, 
2004). Thus, understanding the prevalence of S. aureus 
among various women groups in our society is clinically 
important for the implication of measures to control the 
spread of S. aureus. 
It can be concluded that the results from this study 
show the need to reassess policies on antibiotics use 
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